Overview
William Dalton is an Oncologist in Baltimore, Maryland. Dr. Dalton is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Pancreaticoduodenectomy.
His clinical research consists of co-authoring 36 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Acute Myeloid Leukemia (AML).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
600 N Wolfe St, Blalock 266, Baltimore, MD 21287
5755 Cedar Ln, Columbia, MD 21044
5759 Cedar Ln, Columbia, MD 21044
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins University
Mark Levis is an Oncologist in Bethesda, Maryland. Dr. Levis is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.
Christopher Hourigan is an Oncologist in Baltimore, Maryland. Dr. Hourigan is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Childhood Acute Myeloid Leukemia, Bone Graft, and Bone Marrow Aspiration.
National Cancer Institute
Steven Gore, MD, earned his undergraduate and doctoral degrees at Yale, performed his residency at the University of Chicago and his oncology fellowship at Johns Hopkins. He rose from instructor to full professor at Johns Hopkins, and, in 2013, he became professor of medicine and director of hematologic malignancies at Yale. Dr. Gore is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Dalton isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Bone Marrow AspirationDr. Dalton isAdvanced. Learn about Bone Marrow Aspiration.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Dalton isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Promyelocytic LeukemiaDr. Dalton isExperienced. Learn about Acute Promyelocytic Leukemia.
- Breast CancerDr. Dalton isExperienced. Learn about Breast Cancer.
- Childhood Acute Myeloid LeukemiaDr. Dalton isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Dalton isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).